Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin

(2016) Keitaro Senoo et al.   AMERICAN JOURNAL OF MEDICINE

Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists

(2016) J. Jaspers Focks et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

(2016) Marco Proietti et al.   Scientific Reports

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score

(2015) Flemming Skjøth et al.   THROMBOSIS AND HAEMOSTASIS

Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants

(2014) Luciane Cruz Lopes et al.   PLoS One

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

(2014) Thomas Vanassche et al.   THROMBOSIS AND HAEMOSTASIS

Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation

(2014) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

(2013) Vanessa Roldán et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate

(2013) Karina Meijer et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation

(2013) Steffi Regpala et al.   THROMBOSIS AND HAEMOSTASIS

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding risk assessment and management in atrial fibrillation patients

(2011) Laurent Fauchier et al.   THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST